Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal cytosine permease, primarily encoded by the FCY2 gene, is a membrane-bound transporter responsible for the uptake of cytosine and purines such as adenine, guanine, and hypoxanthine into fungal cells [UniProt, PubMed]. It belongs to the Nucleobase-Cation Symporter-1 (NCS1) family and operates as an energy-dependent symporter [PubMed, NIH]. This protein is a critical therapeutic target because it facilitates the entry of the antifungal prodrug flucytosine (5-fluorocytosine) into susceptible fungi, such as Candida and Cryptococcus species [NIH, MDPI]. Once inside the cell, flucytosine is converted by cytosine deaminase into 5-fluorouracil, which subsequently inhibits DNA and RNA synthesis [NIH, PubMed]. Because human cells lack a functional equivalent of this specific cytosine permease, the pathway provides a high degree of selective toxicity [NIH]. However, mutations in the FCY2 gene are a common mechanism of clinical resistance to flucytosine, often necessitating its use in combination with other antifungals like amphotericin B [MDPI, PubMed].
Facilitates the intracellular uptake of the prodrug flucytosine into fungal cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purine-cytosine permease (FCY2) (FCY2).